Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Expanding the Progeroid Laminopathy Spectrum: Clinical Variability and Later-Onset Phenotype in Homozygous LMNA c.1579C>T (p.Arg527Cys) Associated Mandibuloacral Dysplasia.

Created on 20 Sep 2026

Authors

Eszter Sara Arany, David Zocche, Jan Cobben

Published in

Case reports in genetics. Volume 2026. Pages 5579887. Epub Sep 19, 2026.

Abstract

Homozygous LMNA c.1579C>T p.(Arg527Cys) has previously been reported in seven families and is associated with a progeroid phenotype intermediate between Hutchinson-Gilford progeria syndrome (HGPS) and mandibuloacral dysplasia type A (MAD-A). Due to the limited number of reported cases, the complete phenotypic spectrum associated with this variant remains poorly understood. Here, we describe two Syrian siblings born to consanguineous parents, both homozygous for the LMNA p.Arg527Cys variant. Unlike previously reported cases, these siblings demonstrated a notably delayed onset of clinical symptoms. Both patients exhibited severe generalized lipodystrophy, pronounced progeroid facial dysmorphism, mandibular hypoplasia with severe micrognathia, and pan-digital acro-osteolysis. Our findings expand the recognized clinical spectrum associated with the homozygous LMNA p.Arg527Cys variant and illustrate intrafamilial variability in age of onset within an otherwise relatively homogeneous phenotype.

PMID:
42763606
Bibliographic data and abstract were imported from PubMed on 20 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement